Tradestie Institutional Equity Comparison Engine

IONS vs PTGX โ€” Head-to-Head Terminal

6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.

Market Close: 2026-11-16 Buy Verdict Report Ask Alpha

Pillar 1 Executive Scorecard & Category Winner Tally

PTGX Overall Edge

PTGX Captures Institutional Edge (4โ€“0 Pillars ยท 9โ€“1 Matrix Metrics)

Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Protagonist Therapeutics, Inc (PTGX) driven by superior Valuation, Growth & Margin, Momentum & Technical, Options & Structure. Fundamentally, IONS trades at 90.9x Forward P/E with -58.8% operating margin (+54.9% YoY revenue) versus PTGX at 36.9x Forward P/E and 58.6% operating margin (+5723.6% YoY). In options structure, IONS sits in BREAKDOWN (17th %ile IV; Dealer Gamma Walls on Pro) against PTGX sits in CONSOLIDATION (3rd %ile IV; Dealer Gamma Walls on Pro).

Valuation Winner PTGX
IONS 90.9x vs PTGX 36.9x Fwd P/E
Growth & Margin Winner PTGX
Op Margin -58.8% vs 58.6% ยท YoY +54.9% vs +5723.6%
Momentum & Technical Winner PTGX
1Y -59.1% vs +50.6% ยท 52W Pos 2% vs 58%
Options & Structure Winner PTGX
BREAKDOWN (17th %ile IV) vs CONSOLIDATION (3rd %ile IV)
IONS NASDAQ
Ionis Pharmaceuticals, Inc. Common Stock
Pharmaceutical Preparations
$28.57
-1.7% 1D
Market Cap $4.7B
1M Return -33.48%
1Y Return -59.1%
Forward P/E 90.9x
Unified AI Score
63.9 / 100 BUY
Tech 60.0 Fund 63.0 Flow 73.0 Mom 55.0
PTGX NASDAQ
Protagonist Therapeutics, Inc
Pharmaceutical Preparations
$125.40
-4.24% 1D
Market Cap $8.7B
1M Return -2.6%
1Y Return +50.65%
Forward P/E 36.9x
Unified AI Score
32.6 / 100 SELL
Tech 17.0 Fund 44.0 Flow 67.0 Mom 60.0

Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)

1Y Indexed Return: IONS -59.1% PTGX +50.65% Spread: +109.75 pp (PTGX Lead)

Pillar 3 Multi-Year Annual Revenue & Operating Margin Trajectory (USD)

Split-Invariant Revenue ($B) & Operating Margin (%)
Period IONS Revenue PTGX Revenue IONS Op. Margin PTGX Op. Margin Margin Edge
FY2018 $600M $30M -10.2% -136.7% IONS
FY2019 $1.12B $0M 32.6% -34857.6% IONS
FY2020 $730M $30M -23.6% -225.4% IONS
FY2021 $810M $30M -3.7% -460.0% IONS
FY2022 $590M $30M -69.8% -494.2% IONS
FY2023 $790M $60M -44.9% -156.1% IONS
FY2024 $710M $430M -67.4% 58.2% PTGX
FY2025 $940M $50M -40.4% -343.6% IONS

Pillar 4 Head-to-Head Fundamental & Valuation Matrix

Matrix Tally: IONS (1) vs PTGX (9)
Institutional Metric IONS PTGX Criterion Row Winner
Market Capitalization Scale $4.7B $8.7B Larger Scale PTGX
Trailing P/E Ratio Valuation 90.9x 28.1x Lower Multiple PTGX
Forward P/E Ratio Valuation 90.9x 36.9x Lower Multiple PTGX
Revenue Growth (YoY) Growth +54.9% +5723.6% Higher Growth PTGX
Operating Margin (TTM) Profitability -58.8% 58.6% Higher Margin PTGX
Net Profit Margin Profitability -56.9% 62.0% Higher Margin PTGX
Return on Equity (ROE) Capital Efficiency -108.0% 39.6% Higher ROE PTGX
52-Week Range Position Momentum 2% ($27โ€“$87) 58% ($77โ€“$161) Stronger Trend PTGX
Beta / 30D Volatility Risk Regime 0.18ฮฒ ยท 86% Vol 1.02ฮฒ ยท 35% Vol Lower Realized Risk PTGX
Unified Institutional Score Composite Signal 63.9 / 100 (BUY) 32.6 / 100 (SELL) Higher Composite IONS

Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor

Full IONS vs PTGX Buy Guide
IONS BREAKDOWN
58d in phase ยท OBV DISTRIBUTION
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile 17th %ile
IV Regime Compressed (<25th %ile)
Live IONS Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →
PTGX CONSOLIDATION
64d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile 3rd %ile
IV Regime Compressed (<25th %ile)
Live PTGX Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →

Pillar 6 90-Day Technical & R&D Innovation Disclosures

Corporate R&D & Foundry Tracker
Neither IONS nor PTGX registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.